R-2.2.0.0.01 - Opioid-related Damages and Health Care Costs Recovery Act

Full text
20. If the Government establishes the elements of proof required under section 19, the court presumes
(1)  that the persons who were exposed to the type of opioid products manufactured or promoted by the defendant would not have been exposed to that type of products had the defendant not failed in its duty; and
(2)  that the exposure to the type of opioid products manufactured or promoted by the defendant caused or contributed to the disease, injury or illness, or the risk of disease, injury or illness, of a number of persons who were exposed to that type of products.
2023, c. 25, s. 20.